Your browser doesn't support javascript.
loading
hsa-miR-17-5p: A Possible Predictor of Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir ± Ribavirin Therapy Efficacy in Hepatitis C Infection.
Öksüz, Zehra; Üçbilek, Enver; Serin, Mehmet Sami; Yaras, Serkan; Temel, Gülhan Örekici; Sezgin, Orhan.
Afiliação
  • Öksüz Z; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Mersin University, Mersin, Turkey. zehraoksz@gmail.com.
  • Üçbilek E; Department of Gastroenterology, Faculty of Medicine, Mersin University, Mersin, Turkey.
  • Serin MS; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Mersin University, Mersin, Turkey.
  • Yaras S; Department of Gastroenterology, Faculty of Medicine, Mersin University, Mersin, Turkey.
  • Temel GÖ; Department of Biostatistics, Faculty of Medicine, Mersin University, Mersin, Turkey.
  • Sezgin O; Department of Gastroenterology, Faculty of Medicine, Mersin University, Mersin, Turkey.
Curr Microbiol ; 79(6): 186, 2022 May 07.
Article em En | MEDLINE | ID: mdl-35524830
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C / MicroRNAs / Compostos Macrocíclicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C / MicroRNAs / Compostos Macrocíclicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article